Russell R. Boraddus

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

Jeffrey E. Lee, K. Hess, F. Meric-Bernstam, 2019, Journal of Immunotherapy for Cancer.